Research and Markets (http://www.researchandmarkets.com/research/xlvkj4/cancer) has announced the addition of the "Cancer Cachexia-Pipeline Insights, 2016" report to their offering.

Cancer Cachexia-Pipeline Insights, 2016 provides in depth insights on the pipeline drugs and their development activities around the Cancer Cachexia. The report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.

Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.

The report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Cancer Cachexia.

The report also assesses the Cancer Cachexia therapeutics by Monotherapy, Combination products, molecule type and Route of Administration.

Scope

  • The report provides competitive pipeline landscape of Cancer Cachexia
  • The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
  • Coverage of the Cancer Cachexia pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
  • The report reviews key players involved in the therapeutics development for Cancer Cachexia and also provide company profiling
  • The report also gives the information of dormant and discontinued pipeline projects
  • Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Key Topics Covered:

  1. Cancer Cachexia Overview
  2. Cancer Cachexia Pipeline Therapeutics
  3. Cancer Cachexia Therapeutics under Development by Companies
  4. Cancer Cachexia Filed and Phase III Products
  5. Comparative Analysis
  6. Cancer Cachexia Phase II Products
  7. Cancer Cachexia Phase I and IND Filed Products
  8. Cancer Cachexia Discovery and Pre-Clinical Stage Products
  9. Cancer Cachexia - Therapeutics Assessment
  10. Assessment by Monotherapy Products
  11. Assessment by Combination Products
  12. Assessment by Route of Administration
  13. Assessment by Molecule Type
  14. Cancer Cachexia - Discontinued Products
  15. Cancer Cachexia - Dormant Products
  16. Companies Involved in Therapeutics Development for Cancer Cachexia

For more information visit http://www.researchandmarkets.com/research/xlvkj4/cancer